Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

FDA advisory committee meets this week to discuss Celebrex NDA

Nov. 30, 1998

Immunex files sBLA for Enbrel as treatment for juvenile rheumatoid arthritis

Nov. 27, 1998

British Biotech expands pipeline of MMP inhibitors

Nov. 27, 1998

Amarillo Biosciences initiates phase III clinical trial with oral interferon alfa

Nov. 27, 1998

Merck & Co. synthesizes potent and orally active p38 inhibitor

Nov. 25, 1998

COX-2-specific inhibitor from Merck filed for approval with FDA

Nov. 24, 1998

Immunex receives U.S. patent protection for TACE

Nov. 24, 1998

Antiinflammatory tetrazoles in development at Ono

Nov. 23, 1998

Osteoclast differentiation inhibitors for arthritis under study at Sumitomo

Nov. 23, 1998

Thalidomide analogue CC-1069 shows potent antiarthritic activity in rat model

Nov. 20, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 7, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...